NOX4 silencing or antioxidant (NAC or DPI) treatment reduced the enhancement in intracellular ROS, caspase-3 activity, cytotoxicity, and the PERK-ATF4-CHOP signaling pathway in KA-treated breast cancer cells. The gene discussed is ATF4; the disease is breast cancer.